DCPrime's Corporate Minority Round

DCPrime raised a round of funding on October 29, 2014. Investors include SkylineDx.

DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology. This platform combines antigen carrier properties with the immune-stimulatory pr…

Articles about DCPrime's Corporate Minority Round: